Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Albany Molecular Research Inc (AMRI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Albany Molecular Research Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1065087.
Total stock buying since 2014: $2,180,300.
Total stock sales since 2014: $21,167,933.
Total stock option exercises since 2014: $1,441,840.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2017 | 0 | $0 | 0 | $0 | 15,000 | $217,050 |
| 2016 | 25,000 | $321,000 | 24,547 | $389,190 | 24,000 | $281,648 |
| 2015 | 40,000 | $731,000 | 576,322 | $10,445,389 | 71,617 | $545,863 |
| 2014 | 70,000 | $1,128,300 | 540,694 | $10,333,354 | 78,000 | $397,279 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2017-05 | 0 | $0 | 0 | $0 | 15,000 | $217,050 |
| 2016-11 | 0 | $0 | 15,785 | $265,570 | 9,000 | $118,800 |
| 2016-10 | 0 | $0 | 0 | $0 | 5,000 | $59,150 |
| 2016-08 | 0 | $0 | 1,401 | $21,421 | 0 | $0 |
| 2016-05 | 25,000 | $321,000 | 7,361 | $102,199 | 10,000 | $103,698 |
| 2015-11 | 0 | $0 | 100,000 | $1,960,000 | 0 | $0 |
| 2015-08 | 0 | $0 | 6,000 | $125,750 | 6,000 | $79,200 |
| 2015-06 | 10,000 | $199,800 | 75,787 | $1,496,858 | 5,000 | $52,150 |
| 2015-05 | 0 | $0 | 84,500 | $1,580,107 | 14,500 | $145,797 |
| 2015-04 | 0 | $0 | 70,000 | $1,256,270 | 22,367 | $95,954 |
| 2015-03 | 30,000 | $531,200 | 84,662 | $1,466,464 | 10,000 | $118,500 |
| 2015-02 | 0 | $0 | 85,373 | $1,417,189 | 13,750 | $54,262 |
| 2015-01 | 0 | $0 | 70,000 | $1,142,751 | 0 | $0 |
| 2014-12 | 0 | $0 | 70,000 | $1,129,646 | 0 | $0 |
| 2014-11 | 30,000 | $510,300 | 88,000 | $1,669,095 | 18,000 | $132,180 |
| 2014-10 | 0 | $0 | 71,000 | $1,534,460 | 0 | $0 |
| 2014-09 | 0 | $0 | 72,500 | $1,432,700 | 0 | $0 |
| 2014-08 | 0 | $0 | 124,547 | $2,365,447 | 51,250 | $239,462 |
| 2014-07 | 0 | $0 | 72,500 | $1,519,120 | 0 | $0 |
| 2014-06 | 0 | $0 | 35,000 | $575,124 | 2,500 | $7,325 |
| 2014-05 | 40,000 | $618,000 | 7,147 | $107,762 | 6,250 | $18,312 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-26 | Roth Arthur J (Director) | Option Ex | 5,000 | 14.47 | 72,350 |
| 2017-05-25 | Oconnor Kevin (Director) | Option Ex | 5,000 | 14.47 | 72,350 |
| 2017-05-10 | Ryan Una S (Director) | Option Ex | 5,000 | 14.47 | 72,350 |
| 2016-11-30 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 9,000 | 16.71 | 150,390 |
| 2016-11-30 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Option Ex | 9,000 | 13.20 | 118,800 |
| 2016-11-16 | Henderson Lori M. (SVP, Secretary & Gen Counsel) | Sale | 6,000 | 17.00 | 102,000 |
| 2016-11-10 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 785 | 16.79 | 13,180 |
| 2016-10-05 | Ryan Una S (Director) | Option Ex | 5,000 | 11.83 | 59,150 |
| 2016-08-09 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 1,401 | 15.29 | 21,421 |
| 2016-05-31 | Roth Arthur J (Director) | Option Ex | 5,000 | 10.37 | 51,849 |
| 2016-05-31 | Oconnor Kevin (Director) | Sale | 5,000 | 14.41 | 72,050 |
| 2016-05-31 | Oconnor Kevin (Director) | Option Ex | 5,000 | 10.37 | 51,849 |
| 2016-05-16 | Marth William S (President and CEO) | Buy | 12,500 | 12.86 | 160,750 |
| 2016-05-13 | Svokos George (Chief Operating Officer) | Buy | 12,500 | 12.82 | 160,250 |
| 2016-05-13 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 2,361 | 12.77 | 30,149 |
| 2015-11-09 | D Ambra Thomas E (Director) | Sale | 50,000 | 19.60 | 980,000 |
| 2015-11-09 | D Ambra Constance M (10% Owner) | Sale | 50,000 | 19.60 | 980,000 |
| 2015-08-17 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 1,000 | 20.45 | 20,450 |
| 2015-08-17 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Option Ex | 1,000 | 13.20 | 13,200 |
| 2015-08-07 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 5,000 | 21.06 | 105,300 |
| 2015-08-07 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Option Ex | 5,000 | 13.20 | 66,000 |
| 2015-06-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 19.77 | 395,400 |
| 2015-06-10 | D Ambra Constance M | Sale | 20,000 | 19.77 | 395,400 |
| 2015-06-08 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 5,000 | 19.99 | 99,949 |
| 2015-06-08 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Option Ex | 5,000 | 10.43 | 52,150 |
| 2015-06-04 | Marth William S (President and CEO) | Buy | 10,000 | 19.98 | 199,800 |
| 2015-06-04 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 787 | 19.58 | 15,409 |
| 2015-06-01 | Cable Stuart M | Sale | 30,000 | 19.69 | 590,700 |
| 2015-05-11 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 19.11 | 382,200 |
| 2015-05-11 | D Ambra Constance M | Sale | 20,000 | 19.11 | 382,200 |
| 2015-05-08 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 14,500 | 19.27 | 279,487 |
| 2015-05-08 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Option Ex | 14,500 | 10.05 | 145,797 |
| 2015-05-01 | Cable Stuart M | Sale | 30,000 | 17.87 | 536,220 |
| 2015-04-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 18.50 | 370,000 |
| 2015-04-10 | D Ambra Constance M | Sale | 20,000 | 18.50 | 370,000 |
| 2015-04-07 | Marth William S (President and CEO) | Option Ex | 22,367 | 4.29 | 95,954 |
| 2015-04-01 | Cable Stuart M | Sale | 30,000 | 17.21 | 516,270 |
| 2015-03-17 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 3,500 | 18.53 | 64,855 |
| 2015-03-13 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 441 | 18.79 | 8,286 |
| 2015-03-12 | Roth Arthur J | Sale | 5,000 | 18.26 | 91,300 |
| 2015-03-12 | Roth Arthur J | Option Ex | 5,000 | 11.85 | 59,250 |
| 2015-03-12 | Oconnor Kevin | Sale | 5,000 | 18.22 | 91,100 |
| 2015-03-12 | Oconnor Kevin | Option Ex | 5,000 | 11.85 | 59,250 |
| 2015-03-11 | Hagen Steven R (SVP Manufacturing & Pharmaceut) | Sale | 721 | 18.30 | 13,194 |
| 2015-03-10 | Svokos George (Chief Commercial Officer) | Buy | 10,000 | 17.72 | 177,200 |
| 2015-03-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 17.65 | 353,000 |
| 2015-03-10 | D Ambra Constance M | Sale | 20,000 | 17.65 | 353,000 |
| 2015-03-05 | Marth William S (President and CEO) | Buy | 20,000 | 17.70 | 354,000 |
| 2015-03-02 | Cable Stuart M | Sale | 30,000 | 16.39 | 491,729 |
| 2015-02-25 | Nolan Michael M (CFO) | Sale | 5,000 | 16.17 | 80,850 |
| 2015-02-25 | Nolan Michael M (CFO) | Option Ex | 5,000 | 3.43 | 17,150 |
| 2015-02-23 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 3,750 | 16.22 | 60,824 |
| 2015-02-23 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 3,750 | 5.99 | 22,462 |
| 2015-02-18 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 6,623 | 16.51 | 109,365 |
| 2015-02-18 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 5,000 | 2.93 | 14,650 |
| 2015-02-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 16.91 | 338,200 |
| 2015-02-10 | D Ambra Constance M | Sale | 20,000 | 16.91 | 338,200 |
| 2015-02-02 | Cable Stuart M | Sale | 30,000 | 16.32 | 489,750 |
| 2015-01-12 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 16.45 | 329,000 |
| 2015-01-12 | D Ambra Constance M | Sale | 20,000 | 16.45 | 329,000 |
| 2015-01-07 | Cable Stuart M | Sale | 7,694 | 16.00 | 123,104 |
| 2015-01-05 | Cable Stuart M | Sale | 22,306 | 16.21 | 361,647 |
| 2014-12-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 16.24 | 324,799 |
| 2014-12-10 | D Ambra Constance M | Sale | 20,000 | 16.24 | 324,799 |
| 2014-12-05 | Cable Stuart M | Sale | 13,307 | 16.00 | 212,938 |
| 2014-12-04 | Cable Stuart M | Sale | 10,391 | 16.00 | 166,266 |
| 2014-12-03 | Cable Stuart M | Sale | 6,302 | 16.00 | 100,844 |
| 2014-11-14 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 10,500 | 16.06 | 168,630 |
| 2014-11-14 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 10,500 | 8.31 | 87,255 |
| 2014-11-10 | Marth William S (President and CEO) | Buy | 30,000 | 17.01 | 510,300 |
| 2014-11-10 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 7,500 | 17.03 | 127,725 |
| 2014-11-10 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 7,500 | 5.99 | 44,925 |
| 2014-11-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 17.07 | 341,400 |
| 2014-11-10 | D Ambra Constance M | Sale | 20,000 | 17.07 | 341,400 |
| 2014-11-03 | Cable Stuart M | Sale | 30,000 | 23.00 | 689,940 |
| 2014-10-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 21.62 | 432,400 |
| 2014-10-10 | D Ambra Constance M | Sale | 20,000 | 21.62 | 432,400 |
| 2014-10-01 | Cable Stuart M | Sale | 30,000 | 21.61 | 648,180 |
| 2014-10-01 | Henderson Lori M (SVP, Secretary & Gen. Counsel) | Sale | 1,000 | 21.48 | 21,480 |
| 2014-09-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 20.12 | 402,400 |
| 2014-09-10 | D Ambra Constance M | Sale | 20,000 | 20.12 | 402,400 |
| 2014-09-02 | Cable Stuart M | Sale | 30,000 | 19.30 | 579,000 |
| 2014-09-02 | Henderson Lori M (SVP, Secretary & Gen. Counsel) | Sale | 2,500 | 19.56 | 48,900 |
| 2014-08-28 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 1,250 | 19.74 | 24,674 |
| 2014-08-28 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 1,250 | 5.25 | 6,562 |
| 2014-08-14 | Nolan Michael M (SVP, CFO and Treasurer) | Sale | 10,000 | 19.76 | 197,600 |
| 2014-08-14 | Nolan Michael M (SVP, CFO and Treasurer) | Option Ex | 10,000 | 3.43 | 34,300 |
| 2014-08-12 | Henderson Lori M (SVP, Secretary & Gen. Counsel) | Sale | 30,000 | 19.05 | 571,500 |
| 2014-08-12 | Henderson Lori M (SVP, Secretary & Gen. Counsel) | Option Ex | 30,000 | 4.87 | 146,100 |
| 2014-08-11 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 18.99 | 379,799 |
| 2014-08-11 | D Ambra Constance M | Sale | 20,000 | 18.99 | 379,799 |
| 2014-08-08 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 10,797 | 18.99 | 205,035 |
| 2014-08-08 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 10,000 | 5.25 | 52,500 |
| 2014-08-01 | Cable Stuart M | Sale | 30,000 | 18.69 | 560,640 |
| 2014-08-01 | Henderson Lori M (SVP, Secretary & Gen. Counsel) | Sale | 2,500 | 18.56 | 46,400 |
| 2014-07-10 | D Ambra Thomas E Phd (Chairman, Board of Directors) | Sale | 20,000 | 20.94 | 418,800 |
| 2014-07-10 | D Ambra Constance M | Sale | 20,000 | 20.94 | 418,800 |
| 2014-07-01 | Cable Stuart M | Sale | 30,000 | 21.00 | 629,970 |
| 2014-07-01 | Henderson Lori M (SVP, Secretary & Gen. Counsel) | Sale | 2,500 | 20.62 | 51,550 |
| 2014-06-03 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 2,500 | 16.93 | 42,325 |
| 2014-06-03 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 2,500 | 2.93 | 7,325 |
| 2014-06-02 | Cable Stuart M | Sale | 30,000 | 16.40 | 491,999 |
| 2014-06-02 | Henderson Lori M (SVP, Secretary & Gen. Counsel) | Sale | 2,500 | 16.32 | 40,800 |
| 2014-05-16 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 1,250 | 15.45 | 19,312 |
| 2014-05-16 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 1,250 | 2.93 | 3,662 |
| 2014-05-15 | Svokos George (SVP Sales & GM of API) | Buy | 10,000 | 15.60 | 156,000 |
| 2014-05-12 | Marth William S (President and CEO) | Buy | 30,000 | 15.40 | 462,000 |
| 2014-05-12 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 2,500 | 15.27 | 38,175 |
| 2014-05-12 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 2,500 | 2.93 | 7,325 |
| 2014-05-09 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Sale | 3,397 | 14.80 | 50,275 |
| 2014-05-09 | Hagen Steven R (SVP Pharmaceutical Dev & Mfg) | Option Ex | 2,500 | 2.93 | 7,325 |
Insider trading activities including stock purchases, stock sales, and option exercises of AMRI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Albany Molecular Research Inc (symbol AMRI, CIK number 1065087) see the Securities and Exchange Commission (SEC) website.